Your browser doesn't support javascript.
loading
Discontinuation of mechanical bowel preparation in advanced ovarian cancer surgery: an enhanced recovery after surgery (ERAS) initiative
Sánchez-Iglesias, José Luis; Gómez-Hidalgo, Natalia R; Bebia, Vicente; Pérez-Benavente, Asunción; Gil-Moreno, Antonio; Ramirez, José Manuel; Nelson, Gregg.
Afiliación
  • Sánchez-Iglesias, José Luis; Universitat Autònoma de Barcelona. Hospital Universitari Vall d’Hebron. Gynecological Oncology Department. Barcelona. Spain
  • Gómez-Hidalgo, Natalia R; Universitat Autònoma de Barcelona. Hospital Universitari Vall d’Hebron. Gynecological Oncology Department. Barcelona. Spain
  • Bebia, Vicente; Universitat Autònoma de Barcelona. Hospital Universitari Vall d’Hebron. Gynecological Oncology Department. Barcelona. Spain
  • Pérez-Benavente, Asunción; Universitat Autònoma de Barcelona. Hospital Universitari Vall d’Hebron. Gynecological Oncology Department. Barcelona. Spain
  • Gil-Moreno, Antonio; Universitat Autònoma de Barcelona. Hospital Universitari Vall d’Hebron. Gynecological Oncology Department. Barcelona. Spain
  • Ramirez, José Manuel; University Clinic Hospital Lozano Blesa. Department of General Surgery. Division of Colorectal Surgery. Zaragoza. Spain
  • Nelson, Gregg; University of Calgary. Cumming School of Medicine. Tom Baker Cancer Centre. Calgary. Canada
Clin. transl. oncol. (Print) ; 25(1): 236-242, ene. 2023.
Article en En | IBECS | ID: ibc-215837
Biblioteca responsable: ES1.1
Ubicación: ES15. 1 - BNCS
ABSTRACT
Objective To investigate the impact of discontinuation of mechanical bowel preparation in advanced ovarian cancer surgery within the context of the ERAS program. Methods We retrospectively reviewed the medical records of patients with advanced ovarian cancer who underwent cytoreductive surgery with simultaneous colon and/or rectal resection from January 2012 to November 2020. Patients were divided into two groups based on whether preoperative mechanical bowel preparation (MBP) was given (pre-ERAS) or not (post-ERAS). Patient characteristics, including duration of antibiotic treatment, surgical complexity, and incidence of surgical and nonsurgical complications, were compared. Results During the study period, 114 patients who underwent colon and/or rectal resection were examined, of whom 39 received MBP and 75 did not receive MBP (NMBP). On comparison between the two groups, no significant differences were noted in the assessed patient characteristics, including mean age, FIGO stage, ASA class, BMI, or residual tumor. One patient (2.6%) in the MBP group, and 4 patients (5.3%) in the NMBP group experienced an anastomotic leakage (p = 0.11). No significant differences were found with respect to surgical site infection. (p = 0.5).Conclusion MBP was not associated with any specific benefit for advanced ovarian cancer surgery. Gynecologic oncologists who use MBP should consider discontinuing this practice. (AU)
Asunto(s)
Palabras clave
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias Ováricas / Cuidados Preoperatorios Límite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2023 Tipo del documento: Article
Buscar en Google
Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias Ováricas / Cuidados Preoperatorios Límite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2023 Tipo del documento: Article